Judge Hears Arguments In Challenge To Patents On Genes Tied To Breast, Ovarian Cancer

| Feb 10, 2010

U.S. District Judge Robert Sweet on Tuesday considered whether to invalidate Myriad Genetics’ patents on two genes associated with an increased risk of breast and ovarian cancers in a lawsuit that could have far-reaching implications for the biotechnology industry and genetics-based research, the AP/ABC News reports…

Related Posts:

  1. Patents On Breast, Ovarian Cancer Genes Invalidated
  2. Court Rules Against Gene Patents
  3. ABC News Examines Potential Impact Of Utah Bill To Prosecute Women For Illegal Abortions
  4. Senator Grassley Issues Warning About ‘Phantom Pharmacies’ While Tampa Officials Arrest Pharmacists On Fraud Charges
  5. Financial Interests Should Be Clearer To Increase Trust In Science Suggests Study Of Research Behind Anti Diabetes Drug

Filed Under: Medical Malpractice